Coronavirus disease 2019 in a patient with CADASIL syndrome: a case report by E. L. Zaslavskaya, L. G. Zaslavsky, E. I. Baranova, A. M. Alekseeva, N. V. Markov, N. Sh. Zagidullin

Get full text

Molecular mechanisms of the development of atrial fibrillation in patients with type 2 diabetes mellitus: prognostic role of biomarkers of fibrosis and inflammation by V. A. Ionin, E. I. Barashkova, A. M. Ananev, V. A. Pavlova, E. L. Zaslavskaya, E. I. Baranova

Get full text

Biomarkers of inflammation, parameters characterizing obesity and cardiac remodeling in patients with atrial fibrillation and metabolic syndrome by V. A. Ionin, E. I. Baraschkova, E. L. Zaslavskaya, S. E. Nifontov, E. A. Bazhenova, O. D. Belyaeva, E. I. Baranova

Get full text

Efficiency of radiofrequency ablation of pulmonary vein ostium for patients with atrial fibrillation and metabolics by E. L. Zaslavskaya, V. A. Ionin, O. V. Listopad, S. E. Nifontov, K. N. Malikov, A. V. Soboleva, E. I. Baranova

Get full text

THE ROLE OF TRANSFORMING GROWTH FACTOR BETA-1 AND GALECTIN-3 IN FORMATION OF THE LEFT ATRIUM FIBROSIS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AND METABOLIC SYNDROME by E. L. Zaslavskaya, A. N. Morozov, V. A. Ionin, I. Ma, S. Е. Nifontov, Е. I. Baranova, S. M. Yashin, E. V. Shlyakhto

Get full text

Predictors of atrial fibrillation recurrence in patients with metabolic syndrome after pulmonary vein isolation by V. A. Ionin, E. L. Zaslavskaya, E. I. Barashkova, V. A. Pavlova, A. M. Ananev, A. N. Morozov, E. I. Baranova

Get full text

What is the role of profibrogenic and proinflammatory factors in developing atrial fibrillation associated with metabolic syndrome components? by V. A. Ionin, E. I. Barashkova, V. A. Pavlova, G. I. Borisov, K. A. Averchenko, E. L. Zaslavskaya, E. I. Baranova

Get full text

Atrial fibrillation and CHA2DS2VASc score of 1 - is there a problem in clinical practice? by E. I. Baranova, V. A. Pavlova, V. A. Ionin, E. Yu. Petrischeva, O. I. Bliznuk, E. L. Zaslavskaya, I. Ma, D. S. Skuridin, E. V. Shlakhto

Get full text

Molecular mechanisms of left atrial fibrosis development in patients with atrial fibrillation and metabolic syndrome: what biomarkers should be used in clinical practice? by V. A. Ionin, E L Zaslavskaya, E I Barashkova, V A Pavlova, G I Borisov, K A Averchenko, A N Morozov, E I Baranova, E V Schlyachto

Get full text

С(-344)Т polymorphism of aldosterone synthase gene, risk of metabolic syndrome, and atrial fibrillation risk for inhabitants of the Northwest regions of Russia by I. Ma, A. S. Ulitina, V. A. Ionin, E. L. Zaslavskaya, V. V. Miroshnikova, A. A. Panteleeva, O. D. Belyaeva, E. A. Bazhenova, O A. Berkovich, S. N. Pchelina, E. I. Baranova

Get full text

Oral anticoagulants versus vitamin K antagonists in the treatment of non-valvular atrial fibrillation in patients with stage 4-5 chronic kidney disease by E. G. Skorodumova, O. A. Rubanenko, A. O. Rubanenko, S. T. Enginoev, M. A. Kercheva, E. L. Zaslavskaya, E. V. Efremova, E. Yu. Gubareva, I. N. Lyapina, R. M. Velieva, E. A. Skorodumova, A. V. Siverina

Get full text